TROPAN XL (Ditropan XL)5?mg – 50 tablet

USD $41.05

Each Tropan XR contains 5 mg Oxybutynin 50 tablet and is used in the treatment of an overactive bladder and frequent urination.

ATC Classification: G04BD04
Active Ingrediant: Oxybutynin
Generic Name: TROPAN XL
Manufacturer: Sun Pharma
Strength: 5?mg
Dosage Type: Tablet XL
Packaging Type: Foil in Box
Contains: 50 Tab

Examples of Packages sent

Oxybutynin Information


oks i BYOO ti nin


What is this drug used for?

– It is used to treat an overactive bladder.

– It may be given to you for other reasons. Talk with the doctor.

Frequently reported side effects of this drug

– Fatigue

– Headache

– Blurred vision

– Constipation

– Diarrhea

– Nausea

– Loss of strength and energy

– Anxiety

– Trouble sleeping

– Application site redness, irritation, or itching

– Dry mouth

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

– Urinary tract infection like blood in the urine, burning or painful urination, passing a lot of urine, fever, lower abdominal pain, or pelvic pain.

– Severe dizziness

– Passing out

– Confusion

– Sensing things that seem real but are not

– Agitation

– Mood changes

– Lack of sweat

– Unable to pass urine

– Severe abdominal pain

– Muscle weakness

– Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.


Medication Safety Issues

Sound-alike/look-alike issues:

Oxybutynin may be confused with oxyCODONE, OxyCONTIN

Ditropan may be confused with Detrol, diazePAM, Diprivan, dithranol

Geriatric Patients: High-Risk Medication:

Beers Criteria: Oxybutynin is identified in the Beers Criteria as a potentially inappropriate medication in patients 65 years and older due to its strong anticholinergic properties (Beers Criteria [AGS 2019]).

Other safety concerns:

Transdermal patch may contain conducting metal (eg, aluminum); remove patch prior to MRI.


Storage and Stability

Immediate release tablet and syrup: Store at 20?C to 25?C (68?F to 77?F). Protect from light.

Extended release tablet: Store at 25?C (77?F); excursions permitted to 15?C to 30?C (59?F to 86?F). Protect from moisture and humidity.

Topical gel: Store at 20?C to 25?C (68?C to 77?F). Protect from moisture and humidity. Keep away from open flame. Do not store outside the sealed pouch or pump dispenser; apply immediately after removal from the protective pouch or once contents expelled from pump dispenser. Discard used sachets such that accidental application or ingestion by children, pets, or others are avoided.

Transdermal patch: Store at 20?C to 25?C (68?F to 77?F). Protect from moisture and humidity. Do not store outside the sealed pouch; apply immediately after removal from the protective pouch. Discard used patches such that accidental application or ingestion by children, pets, or others is avoided.


Adverse Reactions

As reported with oral administration, unless otherwise noted.

Cardiovascular: Decreased blood pressure, edema, flushing, increased blood pressure, palpitations, peripheral edema, sinus arrhythmia

Central nervous system: Confusion, dizziness (more common with oral), drowsiness, falling, fatigue (oral, topical gel), flank pain, headache (more common with oral), insomnia, nervousness, pain

Dermatologic: Macular eruption (transdermal; application site), pruritus (oral, topical gel), xeroderma

Endocrine & metabolic: Fluid retention, increased serum glucose, increased thirst

Gastrointestinal: Abdominal pain, coated tongue, constipation (more common with oral), diarrhea, dysgeusia, dyspepsia, eructation, flatulence, gastroesophageal reflux disease, nausea, upper abdominal pain, viral gastroenteritis (topical gel), vomiting, xerostomia (more common with oral)

Genitourinary: Cystitis, dysuria (oral, transdermal), increased post-void residual urine volume, pollakiuria, urinary hesitancy, urinary retention, urinary tract infection (oral, topical gel)

Infection: Fungal infection

Local: Application site dermatitis (topical gel), application site erythema (transdermal), application site pruritus (more common with transdermal), application site rash (transdermal), application site reaction (topical gel), application site vesicles (transdermal)

Neuromuscular & skeletal: Arthralgia, asthenia, back pain, limb pain

Ophthalmic: Blurred vision, eye irritation, keratoconjunctivitis sicca, visual disturbance (transdermal), xerophthalmia

Respiratory: Asthma, bronchitis, cough, dry nose, dry throat, hoarseness, nasal congestion, nasopharyngitis (oral, topical gel), oropharyngeal pain, paranasal sinus congestion, pharyngolaryngeal pain, sinus headache, upper respiratory tract infection (oral, topical gel)

Rare but important or life-threatening: Abnormal behavior, agitation, anaphylaxis, angioedema, anorexia, cardiac arrhythmia, chest discomfort, confusion, cycloplegia, decreased gastrointestinal motility, delirium, dizziness, drowsiness, dysphagia, facial edema, frequent bowel movements, glaucoma, hallucination, headache, hot flash, hypersensitivity reaction, hypertension, hypohidrosis, impotence, lactation insufficiency, memory impairment, mydriasis, prolonged Q-T interval on ECG, psychotic reaction, seizure, skin rash, tachycardia, urticaria, voice disorder

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


Dosage Type

Packaging Type


Sun Pharma


There are no reviews yet.

Be the first to review “TROPAN XL (Ditropan XL)5?mg – 50 tablet”

Your email address will not be published. Required fields are marked *